Interstitial brachytherapy as boost for locally advanced T4 head and neck cancer

Brachytherapy

Volumn 8, Issue 4, 2009, Pages 385-391

  Do, Ly ^a   Puthawala, Ajmel ^b   Syed, Nisar ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

Author keywords

Chemoradiation; Head and neck cancer; Interstitial brachytherapy; T4 locally advanced

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADVANCED CANCER; ARTICLE; BONE NECROSIS; CANCER CHEMOTHERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTINUOUS INFUSION; DYSPHAGIA; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HUMAN; INTERSTITIAL RADIATION; MALE; MOUTH CARCINOMA; MOUTH ULCER; MUCOSA INFLAMMATION; OROPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; TREATMENT OUTCOME; TREATMENT RESPONSE; XEROSTOMIA;

BRACHYTHERAPY; CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MOUTH NEOPLASMS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES;

EID: 70349414288     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2009.03.191     Document Type: Article

References (42)

1. Amdur R.J., Parsons J.T., and Mendenhall W.M. Postoperative irradiation of for squamous cell carcinoma of the head and neck: An analysis of treatment results and complications. Int J Radiat Oncol Biol Phys 16 (1989) 25-36
2. Bernier J., Domenge C., and Ozsahin M. Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 350 (2004) 1945-1952
3. Cooper J.S., Pajak T.F., and Forastiere A.A. Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med 350 (2004) 1937-1944
4. Denis F., Garaud P., and Bardet E. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group Randomized Trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced stage oropharynx carcinoma. J Clin Oncol 22 (2004) 69-76
5. Jeremic B., Shibamoto Y., and Stanisavljevic B. Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in locally advanced unresectable squamous cell carcinoma of the head and neck: A prospective randomized trial. Radiother Oncol 43 (1997) 29-37
6. Adelstein D.J., Saxton J.P., and Lavertu P. A phase III randomized trial comparing concurrent chemotherapy and radiotherapy with radiotherapy alone in respectable stage III and IV squamous cell head and neck cancer. Preliminary results. Head Neck 19 (1997) 567-575
7. Soo K.C., Tan E.H., and Wee J. Surgery and adjuvant radiotherapy vs concurrent chemoradiotherapy in stage III/IV nonmetastatic squamous cell head and neck cancer: A randomized comparison. Br J Cancer 93 (2005) 279-286
8. Do L., Puthawala A., and Syed N. T4 locally advanced head and neck cancer treatment outcomes of patients treated with resection followed by radiotherapy or chemoradiotherapy versus patients treated with concurrent chemoradiotherapy alone. Am J Clin Oncol. (2009) June 5 [Epub ahead of print]
9. Samant S., Robbins K.T., and Kumar P. Bone or cartilage invasion by advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 127 (2001) 1451
10. Puthawala A.A., Syed A.M., and Eads D.L. Limited external beam and interstitial 192 iridium irradiation in the treatment of carcinoma of the base of tongue: A ten year experience. Int J Radiat Oncol Biol Phys 14 (1988) 839-848
11. Puthawala A.A., Syed A.M., and Eads D.L. Limited external beam and interstitial 192 iridium irradiation in the treatment of squamous cell carcinoma of the tonsillar region. Int J Radiat Oncol Biol Phys 11 (1985) 1595-1602
12. Gibbs I.C., Le Q.T., and Shah R.D. Long term outcomes after external beam irradiation and brachytherapy boost for base of tongue cancers. Int J Radiat Oncol Biol Phys 57 (2003) 489-494
13. Chen J., Pappas L., and Moeller M.S. Treatment of oropharyngeal squamous cell carcinoma with external beam radiation combined with interstitial brachytherapy. Head Neck 29 (2007) 362-369
14. Bhalavat R.L., Pathak K.A., and Mahantshetty U. Brachytherapy boost: A novel approach for epiglottic carcinoma. Brachytherapy 6 (2007) 212-217
15. Karakoyun-Celik O., Norris C.M., and Tishler R. Definitive radiotherapy with interstitial implant boost for squamous cell carcinoma of the tongue base. Head Neck 27 (2005) 353-361
16. Inoue T., Inoue T., and Teshima T. Phase III trial of high and low dose rate interstitial radiotherapy for early stage oral tongue cancer. Int J Radiat Oncol Biol Phys 36 (1996) 1201-1204
17. American Joint Committee on Cancer. AJCC Cancer Staging Handbook. 6th ed. (2002), Springer-Verlag, New York
18. Hitt R., Lopez-Pousa A., and Martinez-Trufero J. Phase III study comparing cisplatin plus fluorouracil to paclitaxel, cisplatin, and fluorouracil induction chemotherapy followed by chemoradiotherapy in locally advanced head and neck cancer. J Clin Oncol 23 (2005) 8636
19. Vermorken J.B., Remenar E., and van Herpen C. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357 (2007) 1695-1704
20. Posner M.R., Hershock D.M., and Blajman C.R. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 357 (2007) 1705-1715
21. Cmelak A.J., Li S., and Goldwasser M.A. Phase II trial of chemoradiation for organ preservation in respectable stage III or IV squamous cell carcinomas of the larynx or oropharynx: Results of Eastern Cooperative Oncology Group Study E2399. J Clin Oncol 25 (2007) 3971-3977
22. Yousem D.M., Gad K., and Tufano R.P. Resectability issues with head and neck cancer. Am J Neuroradiol 27 (2006) 2024-2036
23. Mendenhall W.M., Stringer S.P., and Amdur R.J. Is radiation therapy a preferred alternative to surgery for squamous cell carcinoma of the base of tongue?. J Clin Oncol 18 (2000) 35-42
24. Jaulerry C., Rodriguez J., and Brunin F. Results of radiation therapy in carcinoma of the base of tongue. The Curie Institute experience with about 166 cases. Cancer 67 (1991) 1532-1538
25. Nose T., Koizumi M., and Nishiyama K. High dose rate interstitial brachytherapy for oropharyngeal carcinoma: Results of 83 lesions in 82 patients. Int J Radiat Oncol Biol Phys 59 (2004) 983-991
26. Levendag P., Nijdam W., and Noever I. Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: Late adverse sequalae and performance status: Can we be more selective and obtain better tissue sparing?. Int J Radiat Oncol Biol Phys 59 (2004) 713-724
27. Yoshimura R., Shibuya H., and Miura M. Quality of life of oral cancer patients after low dose rate interstitial brachytherapy. Int J Radiat Oncol Biol Phys. 73 (2009) 772-778
28. Nijdam W.M., Levendag P.C., and Noever I. Longitudinal changes in quality of life and costs in long term survivors of tumors of the oropharynx treated with brachytherapy or surgery. Brachytherapy 7 (2008) 343-350
29. Schliaphake H., and Jamil M.U. Prospective evaluation of quality of life after oncologic surgery for oral cancer. Int J Oral Maxillofac Surg 31 (2002) 427-433
30. De Graeff A., De Leeuw J.R.J., and Ros W.J.G. A prospective study on the quality of life of patients with cancer of the oral cavity or oropharynx with or without radiotherapy. Oral Oncol 35 (1999) 27-32
31. Eisbruch A., Lyden T., and Bradford C.R. Objective assessment of swallowing dysfunction and aspiration after radiation concurrent with chemotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 53 (2002) 23-28
32. Graner D.E., Foote R.L., and Kasperbauer J.L. Shallow function in patients before and after intra-arterial chemoradiation. Laryngoscope 113 (2003) 573-579
33. Kotz T., Costello R., and Li Y. Swallowing dysfunction after chemoradiation for advanced squamous cell carcinoma of the head and neck. Head Neck 26 (2004) 365-372
34. Carrara-de Angelis E., Feher O., and Barros A.P. Voice and swallowing in patients enrolled in a larynx preservation trial. Arch Otolaryngol Head Neck Surg 129 (2003) 733-738
35. Mittal B.B., Pauloski B.R., and Haraf D.J. Swallowing dysfunction-preventative and rehabilitation strategies in patients with head and neck cancers treated with surgery, radiotherapy and chemotherapy: A critical review. Int J Radiat Oncol Biol Phys 57 (2003) 1219-1230
36. Feng F.Y., Lyden T.H., and Kim H.M. IMRT aimed at reducing dysphagia: Early dose volume effect relationships for swallowing structures. Int J Radiat Oncol Biol Phys 66 (2006) S44-S45
37. Jensen K., Lambertsen K., and Grau C. Dysphagia, aspiration and speech problems after radiotherapy for pharyngeal cancer correlate with dose volume parameters of the supraglottic region. Radiother Oncol 81 (2006) S167
38. Eisbruch A., Lyden T., and Bradford T. Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: Which anatomic structures are affected and can they be spared by IMRT?. Int J Radiat Oncol Biol Phys 60 (2004) 1425-1439
39. Eisbruch A., Levendag P.C., and Feng F.Y. Can IMRT or brachytherapy reduce dysphagia associated with chemoradiotherapy of head and neck cancer? The Michigan and Rotterdam experiences. Int J Radiat Oncol Biol Phys 69 (2007) S40-S42
40. Nijdam W., Levendag P., and Noever I. Cancer in the oropharynx: Cost calculation of different treatment modalities for controlled primaries, relapses and grade III/IV complications. Radiother Oncol 77 (2005) 65-72
41. Nijdam W., Levendag P., and Noever I. Cost analysis comparing brachytherapy versus surgery for primary carcinoma of the tonsillar fossa and/or soft palate. Int J Radiat Oncol Biol Phys 59 (2004) 488-494
42. Jereczek-Fossa B.A., and Orrechia R. Radiotherapy-induced mandibular bone complications. Cancer Treat Rev 28 (2002) 65-74